Peripheral blood stem cell mobilization with a single dose of PEG-filgrastim in patients with multiple myeloma previously treated with radiotherapy

被引：3
|
作者：
Anguita-Compagnon, Alfonso T. [1 ]
Dibarrart, Maria T. [1 ]
Paredes, Laura [1 ]
Araos, Daniel [1 ]
Vargas, Marcela [1 ]
Majlis, Alejandro [1 ]
机构：
[1] Clin Alemana Santiago, Lab Blood Bank & Oncohematol Unit, Vitacura, Chile
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 11期
关键词：
PROGENITOR-CELL; TRANSPLANTATION; PEGFILGRASTIM; ENGRAFTMENT; GUIDELINES;
D O I：
10.1080/10428194.2017.1300895
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2724 / 2727
页数：4
相关论文
共 50 条
  • [21] Erratum: Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    I N M Micallef
    A D Ho
    L M Klein
    S Marulkar
    P J Gandhi
    G Calandra
    P A McSweeney
    Bone Marrow Transplantation, 2011, 46 : 1398 - 1398
  • [22] PEG-filgrastim single dose versus daily filgrastim administration after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies
    Tendas, A.
    Dentamaro, T.
    Cupelli, L.
    Spagnoli, A.
    Bruno, A.
    De Meis, I
    De Angelis, V
    Datturi, T.
    de Fabriths, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 80 - 80
  • [23] A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents
    Lerro, KA
    Medoff, E
    Wu, Y
    Seropian, SE
    Snyder, E
    Krause, D
    Cooper, DL
    BONE MARROW TRANSPLANTATION, 2003, 32 (12) : 1113 - 1117
  • [24] Filgrastim Plus Fixed-Dose Plerixafor is Cost-Effective in Peripheral Blood Hematopoietic Cell Mobilization in Patients with Multiple Myeloma
    Chow, Eric
    Fasan, Omotayo
    Usmani, Saad
    Jacobs, Ryan
    Sun, Danyu
    Plesca, Dragos
    Trivedi, Jigar S.
    Riddagh, Cindy
    Feild, Donna J.
    Avalos, Belinda
    Copelan, Edward A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S270 - S270
  • [25] Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients
    Mazumder, A.
    Kaufman, J.
    Niesvizky, R.
    Lonial, S.
    Vesole, D.
    Jagannath, S.
    LEUKEMIA, 2008, 22 (06) : 1280 - 1281
  • [26] Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients
    A Mazumder
    J Kaufman
    R Niesvizky
    S Lonial
    D Vesole
    S Jagannath
    Leukemia, 2008, 22 : 1280 - 1281
  • [27] Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma
    Lisenko, Katharina
    Baertsch, Marc-Andrea
    Meiser, Renate
    Pavel, Petra
    Bruckner, Thomas
    Kriegsmann, Mark
    Schmitt, Anita
    Witzens-Harig, Mathias
    Ho, Anthony D.
    Hillengass, Jens
    Wuchter, Patrick
    TRANSFUSION, 2017, 57 (10) : 2359 - 2365
  • [28] Comparison of Peripheral Blood Stem Cell Mobilization with Etoposide or Cyclophosphamide in Patients with Multiple Myeloma
    Jung, Sung-Hoon
    Ahn, Seo-Yeon
    Lee, Seung-Shin
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    BLOOD, 2017, 130
  • [29] Peripheral blood stem cell mobilization after Bendamustin pretreatment in patients with Multiple Myeloma
    Poenisch, W.
    Wiesler, J.
    Leiblein, S.
    Edel, E.
    Al-Ali, H. K.
    Basara, N.
    Hegenbart, U.
    Heiss, C.
    Niederwieser, D.
    Goldschmidt, H.
    ONKOLOGIE, 2010, 33 : 262 - 263
  • [30] PREDICTIVE FACTORS FOR SUCCESSFUL PERIPHERAL BLOOD STEM CELL MOBILIZATION IN PATIENTS WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE
    Gokmen, A.
    Yuksel, M. Kurt
    Soydan, E.
    Ozbek, D.
    Koktas, O.
    Kurdal, M.
    Arslan, O.
    Ilhan, O.
    Ozcan, M.
    HAEMATOLOGICA, 2014, 99 : 655 - 656
12345